Adjudicating Cardiovascular Endpoints in Diabetic Kidney Disease Studies

CATHERINE A. TYNER | September 14, 2017

article image
Diabetic kidney disease (DKD) patients have an increased cardiovascular (CV) risk in addition to their increased risk of progression to end-stage renal disease. Recognizing that the FDA and other regulatory agencies have great interest in both the CV and renal safety and efficacy of compounds under development, pharmaceutical companies should consider inclusion of an appropriate approach to adjudication of potential CV events early in the course of planning for development of drugs to treat DKD.

Spotlight

Artemis Hospitals

Artemis Hospitals is a healthcare venture, launched in 2007, by the promoters of the Apollo Tyres Group. Artemis is the first hospital in Gurgaon to be accredited by JCI and NABH. Designed as one of the most advanced in India, Artemis provides an in-depth expertise in the sphere of advanced medical & surgical interventions, comprehensive mix of inpatient and outpatient services. Artemis aims to provide excellent medical care in a compassionate environment and a practice dedicated to pioneering research, empowering the health care professionals and the diverse communities we serve. The clinical procedures followed in the hospital are technologically advanced and supervised by distinguished doctors of international repute. Our endeavor to deliver standard-setting medical care is lead by the needs of the patient; our exceptional medical facilities and unmatched responsiveness has made us one of the most revered hospitals in the country.

OTHER ARTICLES

How Pharma Companies Can Scale Up Their Knowledge Discovery with Semantic Similarity Search

Article | March 6, 2020

Pharma has deep roots in human history with centuries of folk pharmaceutical knowledge offering a hit-and-miss range of natural remedies. But the industry as we know it today actually emerged in the second half of the 19th century when the world’s first factory for the sole production of medicines was found. By the late 19th and early 20th century, some chemical companies had already begun using research labs to explore the medical applications for their products. Fast forward to today and the pharmaceutical sector is a global trillion-dollar industry. However, to ensure the safety and efficacy of drugs, the process of drug discovery and development is under extensive scrutiny and control on both national and global levels.

Read More

What to Watch in 2020: Non-Specialty Drugs

Article | March 1, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

Roche Prepares to Launch COVID-19 Antibody Test System

Article | April 17, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

Top Specialty Pharmacy Therapy Areas

Article | March 16, 2020

Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 billion in total U.S. specialty drug spending in 2017. Industry growth of this magnitude creates challenges for those looking to understand and penetrate the market. It can be difficult, after all, to maintain updated information about high-priority drug therapy areas or facility affiliations in a market that’s constantly changing.

Read More

Spotlight

Artemis Hospitals

Artemis Hospitals is a healthcare venture, launched in 2007, by the promoters of the Apollo Tyres Group. Artemis is the first hospital in Gurgaon to be accredited by JCI and NABH. Designed as one of the most advanced in India, Artemis provides an in-depth expertise in the sphere of advanced medical & surgical interventions, comprehensive mix of inpatient and outpatient services. Artemis aims to provide excellent medical care in a compassionate environment and a practice dedicated to pioneering research, empowering the health care professionals and the diverse communities we serve. The clinical procedures followed in the hospital are technologically advanced and supervised by distinguished doctors of international repute. Our endeavor to deliver standard-setting medical care is lead by the needs of the patient; our exceptional medical facilities and unmatched responsiveness has made us one of the most revered hospitals in the country.

Events